TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more

EMPLOYEE PARTICIPANTS: 19

TOTAL RATINGS: 339

CEO: Michael S. Weiss

HR or Marketing? Claim Your Free Employer Account

TG Therapeutics Mission, Vision & Values

TG Therapeutics Mission Statement

TG Therapeutics was founded with one goal in mind – to leverage scientific advances to develop the best possible treatment options for patients. Today, our focus is on translating that deep understanding of B-cells developing therapies for autoimmune diseases, with a current focus on multiple sclerosis (MS). These are conditions in which dysregulated B-cell activity plays a critical role in driving inflammation and tissue damage. By targeting B-cells with precision, our goal is to meaningfully alter the course of disease and improve how treatment fits into patients’ lives.

TG Therapeutics Vision Statement

How We Work: Find the right science early. We identify programs grounded in strong science and a clear therapeutic rationale, then move quickly to generate decisive clinical data. Design for real-world use. We develop therapies that not only work but work better for patients—reducing treatment burden and increasing flexibility. Focus where we can lead. We invest where our expertise can have the greatest impact. Build with partners. We collaborate with scientists, clinicians, and companies worldwide to advance innovative ideas that can help patients sooner.

TG Therapeutics Values

No one has added TG Therapeutics' values yet.

TG Therapeutics Employee Alignment

TG Therapeutics' mission, vision & values motivate 50% of TG Therapeutics employees. Besides getting paid, the “company mission” is the most important thing about their work for 50% of employees at TG Therapeutics. Comparably data clearly shows that a focused mission statement and cohesive core company values are vital to maintaining employee alignment.

Answer	Percent
Yes	60%
No	40%

Are you proud to be a part of your company?

Answer	Percent
Yes	50%
No	50%

Are you motivated by your company's mission, vision, & values?

Answer	Percent
Very Important	50%
Important	0%
Neutral	50%
Less Important	0%
Not Important	0%

How important was your Company's mission while job searching?

Answer	Percent
Yes	50%
No	50%

Are your company's goals clear, and are you invested in them?

Answer	Percent
Career Advancement Opportunities	0%
Work Life Balance	0%
Company Mission	50%
Healthcare & Benefits	0%
Culture & Environment	50%

Besides your Salary, what's most important to you about work?

Answer	Percent
Boss or Manager	100%
Coworkers	0%
Direct Reports	0%
Company Mission/Vision	0%
No One	0%

To whom do you feel most loyal at work?

Answer	Percent
Company Mission	0%
Comp & Benefits	50%
Co-Workers	0%
Comfort & Familiarity	50%
Career Advancement Opportunities	0%

What's the main reason you stay at your current company?

Answer	Percent
Transparency & Integrity	50%
Teamwork & Winning	0%
Speed & Innovation	0%
Fun & Passionate	50%
Diversity & Inclusion	0%

Which of the following set of Company Values is most meaningful to you?

TG Therapeutics Culture at a Glance

Mission, Vision & Values at Similar Size Companieson Comparably

Rate your company